Osteomyelitis Treatment Market Size, Share, Trends, Growth Outlook

The Global Osteomyelitis Treatment Market Size is estimated to register 7.6% growth over the forecast period from 2024 to 2030.

 

Collaboration among pharmaceutical firms, research institutions, and healthcare organizations is a key catalyst for the growth of the market, expediting the development of osteomyelitis treatments. Industry partnerships play a vital role in combining resources, expertise, and technology, streamlining the research process from its early stages to clinical trials, and eventually reaching market availability. These collaborative efforts contribute significantly to the overall competitiveness and innovation within the osteomyelitis treatment sector. Leading Companies focusing on Advanced Biomaterials and Tissue Engineering, Immunomodulatory Therapies, Digital Health Solutions Remote Patient Monitoring, and others to boost market shares in the industry.

 

Osteomyelitis Treatment Market Overview

The Osteomyelitis Treatment Market is driven by an increasing incidence of osteomyelitis due to factors like diabetes and vascular insufficiency. Technological advancements in diagnosis and treatment, including improved imaging techniques and novel antimicrobial agents, propel market evolution. Global antimicrobial stewardship initiatives influence responsible antibiotic use, emphasizing the development of alternative treatment strategies. Challenges include antibiotic resistance and high treatment costs. Future trends focus on personalized medicine, advanced therapies such as biomaterials and immunomodulation, and the integration of digital health solutions for improved patient monitoring and management.

 

Osteomyelitis Treatment Market Dynamics

Market Trends- Advanced diagnostics in the Osteomyelitis Treatment Market are key to accurately identifying the culprit pathogens, paving the way for effective treatment.

In the Osteomyelitis Treatment Market, advanced diagnostics play a crucial role by providing essential tools for the accurate identification of pathogens responsible for infections. These diagnostic technologies encompass advanced imaging modalities like MRI and CT scans, molecular and genetic testing, and innovative biomarker detection methods. They empower healthcare professionals to precisely identify the causative agents of osteomyelitis, a vital step in tailoring effective treatment strategies, including targeted antibiotic therapies. The incorporation of state-of-the-art diagnostic tools not only improves the accuracy of pathogen identification but also facilitates early detection, enabling prompt intervention and enhancing patient outcomes. The ongoing evolution of advanced diagnostics in osteomyelitis reflects a commitment to more efficient and personalized approaches in diagnosing and treating this severe bone infection.

 

Market Driver- The rising prevalence of chronic diseases and orthopedic conditions is fueling the demand for osteomyelitis treatment, boosting the osteomyelitis treatment market.

The surging prevalence of chronic diseases and orthopedic conditions plays a pivotal role in propelling the demand within the osteomyelitis treatment market. Conditions such as diabetes, vascular insufficiency, and autoimmune disorders heighten the vulnerability to osteomyelitis, a severe bone infection. Additionally, the increased occurrence of orthopedic procedures, encompassing joint replacements and surgeries, amplifies the risk of osteomyelitis development. This heightened prevalence of predisposing factors has triggered a global upswing in osteomyelitis cases. Consequently, there is a mounting requirement for effective treatment modalities to address and cure osteomyelitis, fostering the demand for pharmaceuticals, cutting-edge diagnostic technologies, and inventive therapeutic interventions. This trend underscores the critical nexus between the prevalence of chronic diseases, orthopedic conditions, and the dynamic landscape of the osteomyelitis treatment market.

 

Market Opportunity- Combating antibiotic resistance in osteomyelitis treatment is a global focus.

The imperative to address antibiotic resistance in osteomyelitis treatment has escalated globally due to the increasing prevalence of drug-resistant strains. Research endeavors are intensifying to devise innovative strategies, encompassing the exploration of alternative antimicrobial agents, combination therapies, and targeted drug delivery systems. Additionally, there is a growing emphasis on global antimicrobial stewardship programs, advocating for the prudent use of antibiotics to counteract resistance. Collaborative initiatives involving pharmaceutical companies, research institutions, and healthcare organizations are dedicated to advancing the development of novel treatments effective against antibiotic-resistant osteomyelitis strains. The integration of advanced diagnostic tools and personalized medicine approaches assumes a pivotal role in tailoring treatments to specific infections, optimizing therapeutic outcomes, and minimizing the risk of further antibiotic resistance. The ongoing commitment to combat antibiotic resistance in osteomyelitis underscores the significance of a multidisciplinary and global approach, ensuring effective and sustainable solutions for this challenging medical condition.

 

Market Share Analysis- X-ray osteomyelitis Treatment Market will register the fastest growth

The Global Osteomyelitis Treatment Market is analyzed across X–Ray, Complete Blood Count, C – Reactive Protein, and others. X-Ray is poised to register the fastest growth.  X-ray imaging plays a crucial role in the diagnosis and monitoring of osteomyelitis, aiding in the visualization of bone damage and infection extent. Advancements in X-ray technology, such as digital radiography and cone-beam computed tomography, contribute to accurate and detailed imaging, influencing treatment decisions and patient management. The integration of advanced imaging technologies in osteomyelitis care, including precise X-ray diagnostics, supports timely interventions and enhances overall treatment effectiveness.

 

Market Share Analysis- Antibiotics held a significant market share in 2023

The Global Osteomyelitis Treatment Market is analyzed across various Treatments including Antifungal, Antibiotics, Analgesics, Surgery, and others. Of these, Antibiotics held a significant market share in 2023. The antibiotics osteomyelitis treatment market is driven by the global need to counter drug-resistant strains, emphasizing the development of advanced antibiotics, combination therapies, and targeted drug delivery systems. Antimicrobial stewardship programs promote responsible antibiotic use, while collaborative efforts between pharmaceutical companies, research institutions, and healthcare organizations focus on bringing tailored antibiotics to market. Advancements in diagnostic tools and personalized medicine enhance treatment precision. The market epitomizes a multidisciplinary approach to address antibiotic resistance, aiming for effective and sustainable solutions in osteomyelitis treatment.

Osteomyelitis Treatment Market Segmentation

By Diagnosis

• X-Ray
• Complete Blood Count
• C – Reactive Protein

 

By Treatment

• Antifungal
• Antibiotics
• Analgesics
• Surgery
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Osteomyelitis Treatment Market Companies

• Pfizer Inc (United States)
• Merck and Co (United States)
• Teva Pharmaceutical (Israel)
• Novartis AG (United States)
• GlaxoSmithKline plc (United Kingdom)
• Johnson and Johnson (United States)
• Bayer AG (Germany)
• Bristol-Myers Squibb (United States)
• Sanofi S.A (France)
• Abbott Laboratories (United States)

 

*List not exhaustive

Osteomyelitis Treatment Market Outlook 2023

1 Market Overview

1.1 Introduction to the Osteomyelitis Treatment Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Osteomyelitis Treatment Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Osteomyelitis Treatment Market Companies with Area Served

4.2.2 Products Offerings Global Osteomyelitis Treatment Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Osteomyelitis Treatment Market Trends

6.1 Global Osteomyelitis Treatment Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Osteomyelitis Treatment Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Osteomyelitis Treatment Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Osteomyelitis Treatment Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Osteomyelitis Treatment Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Osteomyelitis Treatment Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Osteomyelitis Treatment Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Osteomyelitis Treatment Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Osteomyelitis Treatment Development Regional Status and Outlook

8.1 Global Osteomyelitis Treatment Revenue (USD Million) By Regions (2018-2022)

8.2 North America Osteomyelitis Treatment Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Osteomyelitis Treatment Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Osteomyelitis Treatment Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Osteomyelitis Treatment Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Osteomyelitis Treatment Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Osteomyelitis Treatment Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Osteomyelitis Treatment Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Osteomyelitis Treatment Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Osteomyelitis Treatment Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) by Applications (2018-2022)

8.5 South America Osteomyelitis Treatment Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Osteomyelitis Treatment Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Osteomyelitis Treatment Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Osteomyelitis Treatment Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Osteomyelitis Treatment Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Osteomyelitis Treatment Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Osteomyelitis Treatment Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Osteomyelitis Treatment Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Osteomyelitis Treatment Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Osteomyelitis Treatment Development Regional Status and Outlook Forecast

11.1 Global Osteomyelitis Treatment Revenue (USD Million) By Regions (2023-2030)

11.2 North America Osteomyelitis Treatment Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Osteomyelitis Treatment Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Osteomyelitis Treatment Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Osteomyelitis Treatment Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Osteomyelitis Treatment Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Osteomyelitis Treatment Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Osteomyelitis Treatment Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Osteomyelitis Treatment Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Osteomyelitis Treatment Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Osteomyelitis Treatment Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Osteomyelitis Treatment Revenue (USD Million), by Applications (2023-2030)

11.5 South America Osteomyelitis Treatment Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Osteomyelitis Treatment Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Osteomyelitis Treatment Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Osteomyelitis Treatment Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Osteomyelitis Treatment Market Companies with Areas Served

Table 3 Products Offerings Global Osteomyelitis Treatment Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Osteomyelitis Treatment Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Osteomyelitis Treatment Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Osteomyelitis Treatment Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Table 11 Global Osteomyelitis Treatment Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Osteomyelitis Treatment Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Osteomyelitis Treatment Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Osteomyelitis Treatment Market Share (%) By Regions (2018-2022)

Table 16 North America Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Table 17 North America Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Table 18 North America Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Table 26 South America Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Table 27 South America Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Table 33 Global Osteomyelitis Treatment Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Osteomyelitis Treatment Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Osteomyelitis Treatment Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Osteomyelitis Treatment Revenue (USD)By Country (2023-2030)

Table 38 North America Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Table 39 North America Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Table 47 South America Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Table 48 South America Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Osteomyelitis Treatment Revenue Market Share (%) By Type (2022)

Figure 5 Global Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Osteomyelitis Treatment Revenue Market Share (%) By Applications (2022)

Figure 7 Global Osteomyelitis Treatment Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Osteomyelitis Treatment Market Share (%) By Regions (2022)

Figure 9 North America Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Osteomyelitis Treatment Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Osteomyelitis Treatment Revenue Market Share (%) By Type (2030)

Figure 26 Global Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Osteomyelitis Treatment Revenue Market Share (%) By Applications (2030)

Figure 28 Global Osteomyelitis Treatment Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Osteomyelitis Treatment Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Osteomyelitis Treatment Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

By Diagnosis

• X-Ray
• Complete Blood Count
• C – Reactive Protein

 

By Treatment

• Antifungal
• Antibiotics
• Analgesics
• Surgery
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)